High-intensity Versus Low-intensity Laser Acupuncture in Chronic, Non-specific Low Back Pain

NCT06280846 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-11-12

No results posted yet for this study

Summary

The purpose of this study is to investigate the efficacy of high-intensity laser acupuncture versus low intensity laser acupuncture on peak torque of trunk extensors, fatigue of trunk extensors, back pain, ROM and function in patients with chronic nonspecific low back pain (CNLBP).

Conditions

  • Chronic Nonspecific Low-back Pain

Interventions

DEVICE

high-intensity laser acupuncture and Exercise therapy program

The patients will receive high-intensity lasers and the treatment will be performed at 15 acupuncture points: unilateral GV3, GV4, and GV5, and bilateral BL 20, BL23, BL24, BL25, BL40 and GB30. Exercise therapy program: The patients will perform an exercise therapy program in the form of: \- strengthening exercises for abdominal and back muscles, - lumbar stabilization exercises. - stretching exercises

DEVICE

low-intensity laser acupuncture and Exercise therapy program

The patients will receive low-intensity lasers and the treatment will be performed at 15 acupuncture points: unilateral GV3, GV4, and GV5, and bilateral BL 20, BL23, BL24, BL25, BL40 and GB30. Exercise therapy program: The patients will perform an exercise therapy program in the form of: \- strengthening exercises for abdominal and back muscles, - lumbar stabilization exercises. - stretching exercises

DEVICE

Sham laser acupuncture

Sham laser acupuncture and exercise therapy program. The patients will receive a sham laser.acupuncture and an exercise therapy program in the form of: - strengthening exercises for abdominal and back muscles, - lumbar stabilization exercises. - stretching exercises

Sponsors & Collaborators

  • King Khalid University

    collaborator OTHER
  • Cairo University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-15
Primary Completion
2024-10-30
Completion
2024-10-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06280846 on ClinicalTrials.gov